Marking a major step in the global expansion strategy of Venus Remedies through its oncology products, this marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA regions In a decisive step towards making its
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region with the product registration from Philippines for bleomycin, a widely used cancer drug Venus Remedies also expects the marketing authorisation
The recent catastrophic disaster in Turkey has left tens of thousands of people dead and thousands more injured. While the rescue phase is complete, the recovery and rehabilitation phase is just beginning. Many hospitals have been demolished and are not functional, and doctors, nurses, and
The hematological cancer therapy market is diverse and highly genericized, with chemotherapies currently accounting for the highest number of marketed drugs. However, the availability of more targeted and innovative therapies means that sales of antibodies, cell therapies and targeted therapies are all set to increase
Genes2Me, a leading Genetic diagnostics and research Company, launched its high throughput RT PCR testing lab for COVID-19 and other Infectious diseases at Gurgaon with a current capacity of testing 15K samples a day. The fully automated high throughput lab is NABL accredited and ICMR approved,
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
